Inhalable Drugs Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Aerosol, Dry Powder Formulation, Spray); Application (Respiratory, Non-Respiratory Diseases)

Report Code: TIPRE00010489 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Inhalable drugs are used for the treatment of chronic respiratory diseases such as asthma, COPD, bronchospasm, as well as non-respiratory diseases such as diabetes and Parkinson's disease. Inhaled corticosteroids help to prevent asthma attacks and improve lung function. Inhalable drugs come in powder and spray form.

MARKET DYNAMICS

The Asia Pacific market is expected to be the fastest-growing segment over the forecast period for inhalable drugs. Various factors such as improving healthcare infrastructure, rising patient awareness, and increasing disposable income will result in favorable growth in this region. Moreover, new market entrants lead to intense competition, which is expected to play an essential role in providing a growth platform to this regional market over the next few years.

MARKET SCOPE

The "Inhalable Drugs Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of inhalable drugs market with detailed market segmentation by product type, procedure type, end user. The inhalable drugs market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in inhalable drugs market and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The inhalable drugs market is segmented on the basis of product and application. Based on product the market is segmented as aerosol, dry powder formulation and spray. On the basis of application, the market is categorized as respiratory and non-respiratory diseases.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the inhalable drugs market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The inhalable drugs market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting inhalable drugs market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the inhalable drugs market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the inhalable drugs market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from inhalable drugs market are anticipated to have lucrative growth opportunities in the future with the rising demand for inhalable drugs in the global market. Below mentioned is the list of few companies engaged in the inhalable drugs market.

The report also includes the profiles of key players in inhalable drugs market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.


  •   AstraZeneca
  •   Boehringer Ingelheim International GmbH
  •   Cipla Inc.
  •   GlaxoSmithKline plc
  •   Mundipharma
  •   Mylan
  •   Sanofi S.A.,
  •   Teicos Pharma Ltd
  •   Vectura
  •   Zambon S.p.A.


The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Inhalable Drugs Market - By Product
1.3.2 Inhalable Drugs Market - By Application
1.3.3 Inhalable Drugs Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. INHALABLE DRUGS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. INHALABLE DRUGS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. INHALABLE DRUGS MARKET - GLOBAL MARKET ANALYSIS
6.1. INHALABLE DRUGS - GLOBAL MARKET OVERVIEW
6.2. INHALABLE DRUGS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. INHALABLE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. AEROSOL
7.3.1. Overview
7.3.2. Aerosol Market Forecast and Analysis
7.4. DRY POWDER FORMULATION
7.4.1. Overview
7.4.2. Dry Powder Formulation Market Forecast and Analysis
7.5. SPRAY
7.5.1. Overview
7.5.2. Spray Market Forecast and Analysis
8. INHALABLE DRUGS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. RESPIRATORY
8.3.1. Overview
8.3.2. Respiratory Market Forecast and Analysis
8.4. NON-RESPIRATORY DISEASES
8.4.1. Overview
8.4.2. Non-Respiratory Diseases Market Forecast and Analysis
9. INHALABLE DRUGS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Inhalable Drugs Market Overview
9.1.2 North America Inhalable Drugs Market Forecasts and Analysis
9.1.3 North America Inhalable Drugs Market Forecasts and Analysis - By Product
9.1.4 North America Inhalable Drugs Market Forecasts and Analysis - By Application
9.1.5 North America Inhalable Drugs Market Forecasts and Analysis - By Countries
9.1.5.1 United States Inhalable Drugs Market
9.1.5.1.1 United States Inhalable Drugs Market by Product
9.1.5.1.2 United States Inhalable Drugs Market by Application
9.1.5.2 Canada Inhalable Drugs Market
9.1.5.2.1 Canada Inhalable Drugs Market by Product
9.1.5.2.2 Canada Inhalable Drugs Market by Application
9.1.5.3 Mexico Inhalable Drugs Market
9.1.5.3.1 Mexico Inhalable Drugs Market by Product
9.1.5.3.2 Mexico Inhalable Drugs Market by Application
9.2. EUROPE
9.2.1 Europe Inhalable Drugs Market Overview
9.2.2 Europe Inhalable Drugs Market Forecasts and Analysis
9.2.3 Europe Inhalable Drugs Market Forecasts and Analysis - By Product
9.2.4 Europe Inhalable Drugs Market Forecasts and Analysis - By Application
9.2.5 Europe Inhalable Drugs Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Inhalable Drugs Market
9.2.5.1.1 Germany Inhalable Drugs Market by Product
9.2.5.1.2 Germany Inhalable Drugs Market by Application
9.2.5.2 France Inhalable Drugs Market
9.2.5.2.1 France Inhalable Drugs Market by Product
9.2.5.2.2 France Inhalable Drugs Market by Application
9.2.5.3 Italy Inhalable Drugs Market
9.2.5.3.1 Italy Inhalable Drugs Market by Product
9.2.5.3.2 Italy Inhalable Drugs Market by Application
9.2.5.4 Spain Inhalable Drugs Market
9.2.5.4.1 Spain Inhalable Drugs Market by Product
9.2.5.4.2 Spain Inhalable Drugs Market by Application
9.2.5.5 United Kingdom Inhalable Drugs Market
9.2.5.5.1 United Kingdom Inhalable Drugs Market by Product
9.2.5.5.2 United Kingdom Inhalable Drugs Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Inhalable Drugs Market Overview
9.3.2 Asia-Pacific Inhalable Drugs Market Forecasts and Analysis
9.3.3 Asia-Pacific Inhalable Drugs Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Inhalable Drugs Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Inhalable Drugs Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Inhalable Drugs Market
9.3.5.1.1 Australia Inhalable Drugs Market by Product
9.3.5.1.2 Australia Inhalable Drugs Market by Application
9.3.5.2 China Inhalable Drugs Market
9.3.5.2.1 China Inhalable Drugs Market by Product
9.3.5.2.2 China Inhalable Drugs Market by Application
9.3.5.3 India Inhalable Drugs Market
9.3.5.3.1 India Inhalable Drugs Market by Product
9.3.5.3.2 India Inhalable Drugs Market by Application
9.3.5.4 Japan Inhalable Drugs Market
9.3.5.4.1 Japan Inhalable Drugs Market by Product
9.3.5.4.2 Japan Inhalable Drugs Market by Application
9.3.5.5 South Korea Inhalable Drugs Market
9.3.5.5.1 South Korea Inhalable Drugs Market by Product
9.3.5.5.2 South Korea Inhalable Drugs Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Inhalable Drugs Market Overview
9.4.2 Middle East and Africa Inhalable Drugs Market Forecasts and Analysis
9.4.3 Middle East and Africa Inhalable Drugs Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Inhalable Drugs Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Inhalable Drugs Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Inhalable Drugs Market
9.4.5.1.1 South Africa Inhalable Drugs Market by Product
9.4.5.1.2 South Africa Inhalable Drugs Market by Application
9.4.5.2 Saudi Arabia Inhalable Drugs Market
9.4.5.2.1 Saudi Arabia Inhalable Drugs Market by Product
9.4.5.2.2 Saudi Arabia Inhalable Drugs Market by Application
9.4.5.3 U.A.E Inhalable Drugs Market
9.4.5.3.1 U.A.E Inhalable Drugs Market by Product
9.4.5.3.2 U.A.E Inhalable Drugs Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Inhalable Drugs Market Overview
9.5.2 South and Central America Inhalable Drugs Market Forecasts and Analysis
9.5.3 South and Central America Inhalable Drugs Market Forecasts and Analysis - By Product
9.5.4 South and Central America Inhalable Drugs Market Forecasts and Analysis - By Application
9.5.5 South and Central America Inhalable Drugs Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Inhalable Drugs Market
9.5.5.1.1 Brazil Inhalable Drugs Market by Product
9.5.5.1.2 Brazil Inhalable Drugs Market by Application
9.5.5.2 Argentina Inhalable Drugs Market
9.5.5.2.1 Argentina Inhalable Drugs Market by Product
9.5.5.2.2 Argentina Inhalable Drugs Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. INHALABLE DRUGS MARKET, KEY COMPANY PROFILES
11.1. ASTRAZENECA
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. BOEHRINGER INGELHEIM INTERNATIONAL GMBH
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. CIPLA INC.
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. GLAXOSMITHKLINE PLC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. MUNDIPHARMA
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. MYLAN
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. SANOFI S.A.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. TEICOS PHARMA LTD
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. VECTURA
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. ZAMBON S.P.A.
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. AstraZeneca
2. Boehringer Ingelheim International GmbH
3. Cipla Inc.
4. GlaxoSmithKline plc
5. Mundipharma
6. Mylan
7. Sanofi S.A.,
8. Teicos Pharma Ltd
9. Vectura
10. Zambon S.p.A.
TIPRE00010489
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking